Abstract. Accumulating evidence suggests that among the 3 human apolipoprotein E (apoE) isoforms encoded by the human APOE gene, the 4 allele may act to exacerbate brain damage in humans and animals. This study aimed to compare the isoform-specific vulnerability conferred by human apoE to ischemic brain damage, using mice expressing human apoE isoforms (apoE2, apoE3, or apoE4) in place of mouse apoE, produced by the gene-targeting technique in embryonic stem cells (knock-in, KI). Homozygous human apoE2 (2/2), apoE3 (3/3), or apoE4 (4/4) KI mice were subjected to permanent focal cerebral ischemia by a modified intraluminal suture method. Twenty-four h thereafter, brain damage, (as estimated by infarct volume and neurologic deficit) was significantly worse in 4/4 KI mice versus 2/2 or 3/3 KI mice (p Ͻ 0.001 for each comparison), with no significant differences between 2/2 and 3/3 KI mice. Immunohistochemistry for human apoE expression revealed similar apoE distribution with no significant difference in the immunostaining intensity among the 3 lines of KI mice. Notably, increased expression of human apoE was detected in neurons and astrocytes in the peri-infarct area, and a punctate expression pattern was evident in the border between the infarct and peri-infarct areas in all KI mice subjected to ischemia. Taken together, our results show that apoE affects the outcome of acute brain damage in an isoform-specific fashion (apoE4 Ͼ apoE3 ϭ apoE2) in genetically engineered mice.
INTRODUCTION
Human apolipoprotein E (apoE), a 299 amino acid 34 kDa protein constituent of plasma lipoproteins, plays a crucial role in lipid and cholesterol transport among various cells (1) . Furthermore, apoE plays a key role in the mobilization and repartitioning of cholesterol and phospholipids during membrane remodeling, repair, and regeneration (2) . Second only to the liver, the brain has some of the highest levels of apoE mRNA (3), which is primarily synthesized by astrocytes (4, 5) . In humans, 3 isoforms (apoE2, apoE3, or apoE4) are encoded by 3 alleles (2, 3, or 4) at a single human APOE gene locus on the long arm of chromosome 19. The apoE3 isoform is the most common form, whereas the apoE2 and apoE4 isoforms are relatively minor variants that differ from the apoE3 isoform by single amino acid substitutions (resulting from a commonly occurring genetic polymorphism). Specifically, the apoE3 isoform has cysteine at amino acid position 112 and arginine at 158; the apoE2 isoform has cysteine at both 112 and 158; and the apoE4 isoform has arginine at both sites (1) .
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The 4 allele of APOE has been implicated in the etiopathogenesis of a variety of diseases. This allele is commonly associated with Alzheimer disease, and it is assumed that the apoE4 isoform promotes cerebral deposition of ␤-amyloid (6, 7) . Accumulating prospective clinical studies have shown that the apoE4 isoform is also associated with higher morbidity in patients with brain injuries such as nonaneurysmal intracerebral hemorrhage (8) , head injury (9-11), boxing-related repetitive traumatic brain injury (12) , and subarachnoid hemorrhage due to aneurysmal rupture (13, 14) . Moreover, in a large meta-analysis, it has been shown that the APOE 4 genotype is a risk factor for stroke and transient ischemic attacks (15) . One implication of the findings cited above is that the apoE4 isoform may have a lesser capacity than the other 2 isoforms to support neuronal recovery after brain damage. Studies of animal models expressing the apoE3 or apoE4 isoforms support an isoform-specific role of apoE in response to CNS injury (16) (17) (18) (19) (20) (21) . Also, some in vitro studies have shown retarded growth and dysfunction of neurons expressing the apoE4 isoform as compared with those expressing the apoE2 or apoE3 isoforms (22) (23) (24) (25) . However, most of the previous studies using genetically engineered mice have made comparisons between the apoE4 and apoE3 isoforms but not the apoE2 isoform. Because the epidemiologic evidence suggests that the APOE 2 allele decreases, whereas the APOE 4 allele increases the risk for Alzheimer disease (6) , it is important to evaluate the isoform-specific function of apoE2 in vivo. We therefore investigated the effects of apoE2, apoE3, or apoE4 isoforms in mice subjected to acute ischemic brain damage. We employed mice expressing each human apoE isoform in place of the murine apoE gene (Apoe), produced by the gene-targeting technique in embryonic stem cells (knock-in, KI), as previously described (26) . Our findings provide further evidence that apoE affects the degree of acute brain damage in an isoform-specific fashion (apoE4 Ͼ apoE3 ϭ apoE2), implying that a single amino acid substitution in human apoE may confer vulnerability to cerebral ischemic insult.
MATERIALS AND METHODS

Animals
Homozygous mice expressing the apoE4 isoform in place of mouse apoE (4/4 KI mice) were generated by the gene-targeting technique taking advantage of homologous recombination in E14TG2aIV embryonic stem cells as previously described (26) . In these mice, a portion of endogenous Apoe DNA (beginning within exon 2 through most of exon 4) was replaced by a transgene consisting of apoE4 cDNA, obtained through in vitro mutagenesis of apoE3 cDNA at codon 158, allowing expression of human apoE protein under the control of endogenous apoE regulatory elements. Homozygous apoE2 (2/2) or apoE3 (3/3) KI mice were produced in the same manner except that the transgenes carried apoE2 or apoE3 cDNA in place of apoE4 cDNA. The nucleotide sequences of the transgene apoE cDNAs were confirmed by sequencing cDNAs prepared from the liver polyA ϩ RNAs of the 3 homozygous strains.
Mouse Genotyping
Genomic DNA was purified from tail clips of each KI homozygous mouse using Automatic Nucleic Acid Isolation System NA-2000 (Kurabo, Osaka, Japan). Twenty l of the polymerase chain reaction (PCR) mixtures contained approximately 0.5 g of genomic DNA, 50 nM of each primer, 0.25 mM each of dNTPs, 0.5 unit of EX Taq polymerase, and 1ϫ EX Taq buffer (Takara, Siga, Japan). The upstream primer (R90) and downstream primers (allele-specific oligonucleotide primers, here renamed as 112Cys, 112Arg, 158Arg, 158Cys) have been previously described (27) . The thermocycling conditions consisted of: an initial denaturation step at 98ЊC for 5 min followed by 30 cycles of 96ЊC for 2 min, 65ЊC for 1 min, and 72ЊC for 2 min (GeneAmp PCR System 9600, Perkin Elmer, Norwalk, CT). Ten l aliquots of the PCR products were electrophoretically separated on a gel containing 0.7% SeaKem agarose (BioWhittaker Molecular Applications, Rockland, ME) and 0.65% SynerGel (Diversified Biotech, Boston, MA) -TAE. Bands were made visible by ultraviolet illumination of ethidium bromide-stained gels.
Immunoblotting
Separate sets of 2/2, 3/3, or 4/4 KI mice as well as C57BL/ 6N mice (Clea Japan, Tokyo, Japan) as a control were used for quantitative analysis of human apoE levels in the brain (n ϭ 5 each, males, aged-matched, 10 weeks of age). As blood is a particularly abundant source of apoE, the brains were perfused transcardially with 100 ml of 10 U/ml heparin in ice-cold 0.1 M phosphate-buffered saline (PBS) to protect against this potential confound. Pieces of the cerebrum were immediately removed and homogenized as described previously (28) . The protein concentration of the resulting supernatant was determined by a Bio-Rad protein assay using bovine IgG as the standard (Bio-Rad, Hercules, CA). Twenty-five or 50 g of proteins were separated on 10% Tris-glycine gels (Novex, San Diego, MA). The separated proteins were electrotransferred to PVDF membranes (Millipore, Bedford, MA). After an initial blocking step, the blots were incubated overnight at 4ЊC with primary antibodies (rabbit polyclonal anti-human apoE IgG, [5 mg/ml, IBL, Gunma, Japan] or mouse apoE-specific hamster monoclonal antibody [874B7] [29] 
Surgical Procedures
Animal housing, care, and the present protocols complied with the ''Principles of Laboratory Animal Care'' and the Guide for the Care and Use of Laboratory Animals (DHHS publication No.
[NIH] 85-23, revised 1985) and were approved beforehand by the Animal Use Ethical Committee of the Saitama Medical Center/School. All mice used in this study were 10-week-old weight-matched males. They were kept at constant room temperature (23ЊC Ϯ 2ЊC) and relative humidity (55% Ϯ 10%) in an air-conditioned room with aeration (15 times/h) under an alternating 12-h cycle of fluorescent light and darkness (light: 7:00 to 19:00). All mice were fed a normal diet (MF [4.9% fat, 0.075% cholesterol, 23.8% protein, 6.2% ash, and 2.7% fiber], Oriental Yeast, Chiba, Japan). All mice were subjected to fasting overnight (12 h) with free access to water before surgical procedures. Anesthesia was induced and maintained with halothane (1.5% to 2% and 0.5%, respectively) in a mixture of 70% nitrous oxide and 30% oxygen under spontaneous ventilation. During the surgical procedure, body temperature was monitored by a rectal probe and maintained normothermic (36.8ЊC-37.3ЊC) with a heating blanket regulated by a homeothermic blanket control unit. Permanent middle cerebral artery occlusion (pMCAO) was produced using the suture method as described previously with minor modifications (30, 31) . Briefly, the left common carotid, external carotid, and internal carotid arteries were isolated. A nylon monofilament (0.074 mm in diameter) with a heat-modified (0.148 mm in diameter) and silicone-coated (2 mm in length and 0.148 mm in diameter) head was gently advanced into the distal internal carotid artery 9 mm from the left carotid bifurcation. The tip of the filament was uniformly positioned in the proximal portion of the anterior cerebral artery, completely occluding the left middle cerebral artery territory at its origin. In the sham operation, the tip of the filament was inserted through the external into the internal carotid artery 5 mm above the left carotid bifurcation, where the tip does not reach the origin of the left middle cerebral artery territory. After filament insertion, regional cerebral blood flow (CBF) was checked transiently at the dorsolateral cerebral cortex of the ischemic hemisphere to validate pMCAO by laser-Doppler flowmetry (Advance Laser Flowmetry, Model ALF-21D; Advance, Tokyo, Japan) as described previously (30) . After exposing and thinning the skull at 1 mm posterior and 4 mm lateral to bregma, the head of the mouse was fixed in a stereotaxic frame (Narishige, Tokyo, Japan), and the tip of the flowmetry probe (0.8 mm in diameter) was secured perpendicular to the skull surface. Thereafter, the wound was closed after applying xylocaine over the operative field. After halothane was discontinued, the mice were returned to their cages. Water and food were then given ad libitum. After 24 h of pMCAO, evaluation of neurologic deficits was graded as follows: score 0, no neurologic deficit; score 1, forelimb flexion; score 2, decreased resistance to lateral push and forelimb flexion without circling; score 3, same behavior as grade 2, with circling, and score 4, inability to walk spontaneously (32) . Evaluation was performed by a single investigator blinded to animal identities.
Determination of Infarct Volume
A total of 30 mice (2/2, 3/3, or 4/4 KI mice; n ϭ 10 each) were randomly assigned for death 24 h after pMCAO. After mice were re-anesthetized with halothane as described above, they were killed by transcardial perfusion with 200 ml of 10 U/ml heparin in saline followed by 200 ml of 4% paraformaldehyde in PBS. The brain was removed and fixed in the same fixative at 4ЊC for 48 h. At predetermined coronal planes, the fixed brain was divided into 2 pieces (cerebrum and cerebellum), and the cerebral piece was routinely embedded in paraffin with 48 h of processing. At 6 different levels, serial sections (5 m in thickness) were cut at sites from the frontal to the occipital poles at 1-mm intervals. Sections obtained from each site were equally spaced and sequentially labeled as slices 1 to 6 prior to hematoxylin and eosin or cresyl violet staining. Stained sections close to the posterior surface of each brain slice were examined to determine the infarct area using a computer-based image analyzer (Scion Image beta 4.02 for Windows, Scion Corporation, Frederic, MD). To exclude the effects of brain edema, the infarct area was corrected by the ratio of the whole area of the affected hemisphere to area of the contralateral hemisphere (32) . The infarct volume was calculated as the sum of the corrected infarct areas in all 6 slices. Measurements and statistical analysis were performed in a blinded manner by a single investigator.
Anatomical Evaluation of the Cerebral Vasculature
To rule out the possibility that the difference in infarct volume following pMCAO was due to anatomical variations in the major cerebral arteries, we examined the development and topographic distribution of the cerebral vasculature in separate sets of 2/2, 3/3, or 4/4 KI mice (n ϭ 10 each) following perfusion with India black ink. After the same anesthesia as described above with halothane, mice were killed by transcardial perfusion with 200 ml of 10 U/ml heparin in saline followed by 200 ml of 4% paraformaldehyde in PBS. India black ink was injected from the ascending aorta. The brain was removed and fixed in the same fixative. After 3 h of postfixation, the brain surface was examined and photographed from the dorsal, ventral, and lateral aspects, and the configuration of the vasculature was compared among 2/2, 3/3, or 4/4 KI mice.
Evaluation of Physiologic Parameters and Regional CBF
As repeated blood withdrawal or continuous monitoring of regional CBF for 30 min is likely to affect the outcome of pMCAO, all parameters (Pao 2 , Paco 2 , pH, MABP, blood glucose, and serum total cholesterol), body temperature, and regional CBF were examined in separate sets of 2/2, 3/3, or 4/4 KI mice (n ϭ 6 each) under halothane anesthesia with spontaneous ventilation as described above. The animals were subjected to fasting overnight (12 h) with free access to water before blood sampling. A femoral artery was cannulated to monitor MABP and to collect a blood sample. The body temperature was monitored using a rectal probe. The above-mentioned physiologic parameters were recorded at 15 min before (except for Pao 2 , Paco 2 , pH, and serum total cholesterol) and 30 min after filament insertion. The regional CBF at the dorsolateral cerebral cortex was determined by the same method as described above. Baseline values were obtained before insertion of the filament. After the filament was inserted into the left internal carotid artery, regional CBF was measured continuously and recorded at 1, 5, 10, 15, 25, and 30 min. The levels of serum total cholesterol were measured using an enzymatic assay kit (Vitros dry total cholesterol kit, Ortho-Clinical Diagnostics, Rochester, NY).
Immunohistochemistry for Detection of Human apoE
To immunohistochemically examine the expression of human apoE in brains from 2/2, 3/3, or 4/4 KI mice subjected to pMCAO (n ϭ 10 each) or sham operation (n ϭ 5 each), additional sections adjacent to the coronal plane of section No. 3 were used. For detecting human apoE in situ, sections were deparaffinized and pretreated by hydrolytic autoclaving in 10 mM citrate buffer (pH 6.0) for 15 min at 121ЊC to retrieve the antigens. Detection of human apoE and glial fibrillary acidic protein (GFAP) was performed according to the manufacturer's protocol using the Vectastain ABC elite kit (Vector Laboratories, Burlingame, CA) coupled with the diaminobenzidine reaction. Rabbit polyclonal anti-human apoE antibody (diluted 1: 200; incubated at 4ЊC overnight, IBL) or rabbit polyclonal anticow GFAP antibody (diluted 1:1,000; incubated at 4ЊC overnight, DAKO, Carpinteria, CA) was employed as the primary antibody. PBS was used instead of primary antibody or ABC reagent as a negative control.
Evaluation of Human apoE Expression
Human apoE expression was evaluated semiquantitatively in sections adjacent to the coronal plane of section No. 3 from 2/ 2, 3/3, or 4/4 KI mice subjected to pMCAO or sham operation. Immunoreactivity was graded as absent (Ϫ), slight (Ϯ), mild (ϩ), or moderate (ϩϩ) in 4 regions (nonischemic, peri-infarct, or infarct areas in ischemic/sham-operated hemispheres, and nonischemic areas in contralateral hemispheres).
Statistical Analysis
Data are presented as the mean Ϯ 1 SD. The KolmogorovSmirnov test was used to determine the normality of the data. If data were not found to be normally distributed, the nonparametric Kruskal-Wallis H test was used to assess significance followed by post-hoc testing using the Mann-Whitney U test. If data were found to be normally distributed, statistical analysis was performed using parametric 1-way analysis of variance (ANOVA) followed by post-hoc testing using Scheffe's or Dunnett's T3 methods as appropriate (where appropriateness was determined using Levene's test for equality of the variance). P values of less than 0.05 were considered to be significant. All analyses were performed using the Statistical Processor for the Social Sciences, release 10.0.1 (SPSS, Chicago, IL).
RESULTS
Expression of Transgenic apoE in Brains of KI Mice
The APOE genotypes of 2/2, 3/3, or 4/4 KI mice were confirmed by allele-specific oligonucleotide-primed PCR. This method relies on detection of amplified products using 1 common upstream primer and 4 downstream allelespecific oligonucleotide primers, 2 of which distinguish a single nucleotide difference at codon 112, and the other 2 of which specifically recognize a difference at codon 158 (27) . For example, in 2/2 KI mice, the 119 bp fragment would be amplified by primer 112Cys but not by primer 112Arg, confirming that cysteine is encoded by codon 112. Similarly, the 257 bp fragment would be amplified by primer 158Cys, confirming that amino acid 158 is cysteine. The correct genotypes were similarly confirmed for 3/3 and 4/4 KI mice (Fig. 1) .
Expression of apoE in brain homogenates from 2/2, 3/3, or 4/4 KI mice was examined using mouse or human apoE antibodies. The mouse apoE band was not detected by Western blotting in 2/2, 3/3, or 4/4 KI mice ( Fig. 2A) . Human apoE-specific antibody detected robust bands of approximately 34 kDa that were not detected in the wildtype mice (C57BL/6N) (Fig. 2B) , confirming that each apoE isoform completely replaced the mouse protein in the 3 lines of KI mice. Quantitative analysis of immunoblots showed that human apoE was present at comparable levels in 3/3 and 4/4 KI mice, and at significantly increased levels in 2/2 (0.57 Ϯ 0.07 ng/50 g) compared to 3/3 (0.41 Ϯ 0.04 ng/50 g) or 4/4 (0.46 Ϯ 0.02 ng/50 g) KI mice (p Ͻ 0.001, 2/2 vs 3/3 KI mice; p Ͻ 0.05, 2/2 vs 4/4 KI mice). These band intensities could not be quantitatively compared to those of the endogenous apoE in the wild-type mice because of the different reactivity of anti-apoE antibodies to human versus mouse apoE protein.
Neurologic Deficits and Infarct Areas and Volumes after Ischemia
Occlusion of the middle cerebral artery at the correct position as well as the absence of subarachnoid hemorrhage or subdural hematoma was visually confirmed in all KI mice when the brains were removed. Mortality was not encountered before the end of the experiment. Moreover, atypical neurologic deficits such as torsion of the Fig. 2 . Detection of human apoE in the 3 lines of KI mice. Homozygous human apoE2, apoE3, or apoE4 KI mice are denoted by 2/2-, 3/3-, or 4/4-KI, respectively. Brain extracts containing 25 or 50 g of protein were electrophoretically separated and immunoblotted with species-specific anti-apoE antibodies. A: Mouse apoE is detected in the brain homogenate of C57BL/6N control wild-type mice but not in the 3 lines of KI mice by mouse apoE-specific hamster monoclonal antibody (874B7), demonstrating elimination of endogenous mouse apoE in the 3 lines of KI mice. B: Human apoE is detected in the brain homogenates of the 3 lines of KI mice using rabbit polyclonal anti-human apoE antibody. neck or rolling fits were not present during the experiment. At 24 h after pMCAO, the neurologic scores were significantly greater in 4/4 KI mice than in 2/2 or 3/3 KI mice (p Ͻ 0.001, respectively), suggesting a poorer neurologic outcome in 4/4 KI mice. No significant differences in neurologic scores were observed between 2/2 and 3/3 KI mice (Fig. 3) .
In the ischemic hemisphere, extensive pallor in the striatum and the cortex was discernible in hematoxylin and eosin-and cresyl violet-stained specimens at 24 h after pMCAO. As shown in Figure 4 , in 2/2, 3/3, or 4/4 KI mice, the sections in coronal planes No. 3 and 4 corresponded to the areas most severely affected by pMCAO. In some of the planes, the infarct area was significantly larger in 4/4 KI mice than in 2/2 (p Ͻ 0.05 in sections 4 and 5; p ϭ 0.001 in section 2) or 3/3 (p Ͻ 0.05 in section 5; p Ͻ 0.01 in section 4; p ϭ 0.001 in section 2) KI mice. No significant differences were found in the infarct areas between 2/2 and 3/3 KI mice in any of the planes examined. In the sham-operated brains of 2/2, 3/3, or 4/4 KI mice, no ischemic change was observed in any of the brain regions examined.
Total Fig. 3 . Neurologic scores at 24 h after pMCAO in the 3 lines of KI mice. Individual scores are plotted as closed circles. Homozygous human apoE2, apoE3, or apoE4 KI mice are denoted by 2/2-, 3/3-, or 4/4-KI, respectively. Statistical analysis was performed by the Kruskal-Wallis H test followed by the Mann-Whitney U test, where significant differences of p Ͻ 0.001 (### vs 2/2-KI mice; *** vs 3/3-KI mice) were found. Fig. 4 . The totaled infarct areas from cortex and striatum at 24 h after pMCAO in the 3 lines of KI mice. Each value is represented as the mean ϩ 1 SD. Homozygous human apoE2, apoE3, or apoE4 KI mice are denoted by 2/2-, 3/3-, or 4/4-KI, respectively. Statistical analysis was performed by 1-way AN-OVA followed by Scheffe's post hoc test, where differences of p Ͻ 0.05 (# vs 2/2-KI mice; * vs 3/3-KI mice), p Ͻ 0.01 (** vs 3/3-KI mice), or p ϭ 0.001 (### vs 2/2-KI mice; *** vs 3/ 3-KI mice) were found.
Fig. 5.
Infarct volumes in the cortex, striatum, and total (cortexϩstriatum) at 24 h after pMCAO in the 3 lines of KI mice. Each value is represented as means ϩ 1 SD. Individual scores are plotted as closed circles. Homozygous human apoE2, apoE3, or apoE4 KI mice are denoted by 2/2-, 3/3-, or 4/4-KI, respectively. Statistical analysis was performed by 1-way AN-OVA followed by Scheffe's post hoc test, where differences of p Ͻ 0.001 (### vs 2/2-KI mice; *** vs 3/3-KI mice) were found. 6 .73 Ϯ 1.31 mm 3 , respectively. As shown in Figure 5 , infarct volumes as totaled in the hemisphere or in the cortex were significantly larger in 4/4 than in 2/2 or 3/3 KI mice (p Ͻ 0.001, respectively). Infarct volumes in the striatum in 4/4 KI mice were not significantly larger than those of 2/2 or 3/3 KI mice. No significant differences in infarct volumes were found between 2/2 and 3/3 KI mice. The significant differences in both infarct areas and volumes demonstrated above indicate that some isoformspecific neuronal vulnerability of human apoE KI mice is enhanced in the acute stage of brain injury. The edema index, namely the ratio of the left hemispheric area to the right, showed no significant differences in any of the planes examined among 2/2, 3/3, or 4/4 KI mice at 24 h after pMCAO.
Anatomical Evaluation of the Cerebral Vasculature
To ascertain whether genetic manipulation of APOE induced an anatomical abnormality of the cerebral vasculature, the circle of Willis, anterior cerebral artery, middle cerebral artery, and posterior cerebral artery as well as their branches were compared in the 3 lines of KI mice. Concerning the middle cerebral artery, no apparent differences in the formation of the M1 segment or in the branching pattern of the more distal segments were observed among 2/2, 3/3, or 4/4 KI mice except for a minor variation of the branching angle. Particular attention was paid to detecting the presence or the absence of the posterior communicating artery, because the lack of the artery has been documented in some strains of mice (33) . In each of the 3 lines of KI mice examined, both of the posterior communicating arteries had a normal configuration, ruling out the possibility of selective neuronal death in the hippocampus due to unilateral occlusion of the common carotid artery (Fig. 6) .
Evaluation of Physiologic Parameters and Regional CBF
Representative data showing intraoperative alterations in blood gases, MABP, blood glucose, serum total cholesterol, and body temperature in 2/2, 3/3, or 4/4 KI mice are shown in Table 1 . These parameters showed no significant differences among 2/2, 3/3, or 4/4 KI mice, except for the levels of serum total cholesterol. The levels Thirty min after pMCAO, these values gradually decreased to 14.80% Ϯ 1.39%, 14.91% Ϯ 2.07%, or 13.52% Ϯ 1.52% of the baseline value, respectively. Thus, at no time point monitored were any significant differences in regional CBF values found among 2/2, 3/ 3, or 4/4 KI mice (Fig. 7) .
Expression of Human apoE
Human apoE immunoreactivity was markedly decreased in the infarct areas of the ischemic hemispheres of 2/2, 3/3, or 4/4 KI mice, being present only in association with a small number of residual neurons and astrocytes (Fig. 8A) . In the neocortex, striatum, and hippocampus of the contralateral hemispheres, as well as in noninfarct areas of the ischemic hemispheres of 2/2, 3/3, or 4/4 KI mice subjected to pMCAO, a considerable number of neurons showed mild expression of human apoE immunoreactivity in their somata and neurites. Also, astrocytes of the resting type in the neocortex (layer I) and the white matter showed mild expression of human apoE immunoreactivity in their somata and processes (Fig. 8B, C) . Such neuronal and astrocytic expression of human apoE immunoreactivity was similarly observed in both hemispheres of 2/2, 3/3, or 4/4 KI mice subjected to sham operation, reflecting the baseline levels of human apoE expression. Interestingly, expression of human apoE in a punctate pattern was consistently detected in the border region between the infarct and peri-infarct areas in 2/2, 3/3, or 4/4 KI mice. Furthermore, some neurons and astrocytes in the peri-infarct areas expressed human apoE more intensely in their processes than others, suggesting that human apoE is functionally expressed under endogenous regulatory control similarly in the brains from 2/2, 3/3, or 4/4 KI mice (Fig. 8D, E) . Such apoEexpressing astrocytes may be in the early stage of activation induced by ischemia, since they also showed increased GFAP immunoreactivity (Fig.  8F ). Semiquantitative evaluation showed no significant differences in the intensity of human apoE expression among 2/2, 3/3, or 4/4 KI mice in any of the regions examined. In each of 2/2, 3/3, or 4/4 KI mice subjected to pMCAO, human apoE immunoreactivity in neurons and astrocytes was significantly enhanced in the peri-infarct areas (p Ͻ 0.001), while it was significantly decreased in the infarct areas (p Ͻ 0.001) compared with nonischemic areas in both hemispheres (Table 2) .
DISCUSSION
Mounting evidence suggests that apoE may influence neuronal responses to injury in an isoform-specific manner. It has been clearly established that the apoE4 isoform is associated with exacerbated ␤-amyloid pathology in Alzheimer disease (6, 7) . Recently, a number of epidemiologic studies have shown that patients carrying the Physiologic variables obtained from a separate set of animals. Each value is represented as the mean Ϯ 1 SD (n ϭ 6 each). Homozygous human apoE2, apoE3, or apoE4 KI mice are denoted by 2/2-, 3/3-, or 4/4-KI, respectively. There were no significant differences among the 3 lines of KI mice with respect to physiologic variables except for the levels of total serum cholesterol. Statistical analysis was performed by 1-way ANOVA followed by Scheffe's post-hoc test, where differences of p Ͻ 0.001 (### vs 2/2-KI mice; *** vs 3/3-KI mice) were found.
Fig. 7.
Regional CBF measured at the dorsolateral cerebral cortex by laser-Doppler flowmetry after pMCAO in the 3 lines of KI mice. Each value is represented as the mean Ϯ 1 SD. Homozygous human apoE2, apoE3, or apoE4 KI mice are denoted by 2/2-, 3/3-, or 4/4-KI, respectively. The regional CBF values of 2/2-, 3/3-, or 4/4-KI mice showed drastic reductions to 24.75% Ϯ 3.20%, 24.50% Ϯ 3.63%, or 22.87% Ϯ 4.95% of the baseline value at 1 min after insertion of the nylon monofilament. These values gradually decreased to levels of 14.80% Ϯ 1.39%, 14.91% Ϯ 2.07%, or 13.52% Ϯ 1.52% of the baseline value, respectively, during the 30 min monitoring period. There were no significant differences among the 3 lines of KI mice. APOE 4 allele respond poorly to a variety of brain injuries (8) (9) (10) (11) (12) (13) (14) (15) . A previous in vivo study has shown that transgenic mice expressing the apoE4 isoform exhibited a 37.5% larger infarct volume and worse neurologic outcome than those expressing the apoE3 isoform using a transient focal ischemic model (16) . In agreement with this, it has been demonstrated that the APOE 4 allele induced an increase in region-specific vulnerability, together with an increase in apoE expression using a transient global forebrain ischemic model (20) . Although a deleterious effect of the APOE 4 allele had been reported, the influence of the APOE 2 allele on outcome after brain injury in genetically engineered mice had not yet been examined. In this regard, in an epidemiologic study it was found that the APOE 2 allele decreases, whereas the APOE 4 allele increases, the risk for Alzheimer disease (6) . Therefore, we felt it important to include the apoE2 isoform in a comparison of apoE isoform-specific responses to focal ischemic brain injury. As mice expressing apoE2, apoE3, or apoE4 isoforms in place of endogenous mouse apoE had already been produced (26), the above line of investigation prompted us to employ these human apoE KI animals to compare the apoE isoform-specific vulnerability of the brains of these mice to cerebral ischemia. Here we demonstrated that brain damage estimated by infarct volume and neurologic deficit was significantly worse in 4/4 KI mice than in 2/ 2 or 3/3 KI mice, with no significant difference between 2/2 and 3/3 KI mice at 24 h after pMCAO. This increased infarct volume in 4/4 KI mice was not ascribable to differences in the development of the cerebral vasculature, physiologic variables during the experiment (except for the level of total serum cholesterol), alterations in regional CBF during 30 min, or distribution/intensity of human apoE expression in situ after ischemia. It is noteworthy that we did not observe a protective effect in 2/2 KI relative to 3/3 KI mice. This result is consistent with a recent large meta-analysis of patients with ischemic cerebrovascular disease and unaffected controls, in which, while the Fig. 8 . Expression of human apoE in brains from homozygous apoE4 KI mice at 24 h after pMCAO. In the infarct area of the operated hemisphere, human apoE immunoreactivity is markedly reduced except for that associated with a few residual neurons and astrocytes (A). In noninfarct areas of the ischemic hemisphere (B) and the contralateral hemisphere (C), a considerable number of neurons show mild expression of human apoE in somata and neurites in the neocortex. Also, mild expression of human apoE is observed in somata and processes of resting astrocytes in the neocortex (layer I) (B, C). Notably, modest expression of human apoE is detected in some neurons (D) and astrocytes (E) in the peri-infarct area, being expressed more intensely in their processes. These astrocytes show increased GFAP immunoreactivity and appear to be in an early stage of astrocytic response to ischemic insult (F). Scale bar ϭ 50 m.
APOE 4 allele was risk-associated, the APOE 2 allele did not confer protection against disease (15) .
In anatomical evaluation of the cerebral vasculature, it has been reported that C57BL/6N mice (the background strain in this study) frequently lack one or both of the posterior communicating arteries that influence the ischemic status (33) . Thus, we paid particular attention to examining the presence of the posterior communicating artery in the 3 lines of KI mice. Our results showed that both of the posterior communicating arteries were detected in all 3 lines of KI mice examined, suggesting that the vascular anatomy of the animals in this study did not affect the outcome of selective neuronal death caused by unilateral occlusion of the common carotid artery.
Regarding the different levels of total serum cholesterol among the 3 lines of KI mice, both 2/2 and 4/4 KI mice, but not 3/3 KI mice, showed hypercholesterolemia. Hypercholesterolemia and consequent compromised vascular physiology could possibly have affected regional CBF or indirectly exacerbated brain damage after p-MCAO. We therefore employed 10-week-old 2/2, 3/3, or 4/4 KI mice to minimize the possibility of vascular preatherosclerotic lesions (the formation of small foci of foamy cells or fatty streaks in the vascular wall) caused by chronic hypercholesterolemia with age. At 10 weeks of age there were no preatherosclerotic lesions (examined by Oil Red O staining) in either the cerebral or peripheral vascular walls (unpublished data). Immunoreactivity of human apoE expression is graded in a semiquantitative fashion as absent (Ϫ), slight (Ϯ), mild (ϩ), or moderate (ϩϩ). Homozygous human apoE2, apoE3, or apoE4 KI mice are denoted by 2/2-, 3/3-, or 4/4-KI, respectively. *Not available. Statistical analysis was performed by the Kruskal-Wallis H test followed by the Mann-Whitney U test, where differences of p Ͻ 0.001 were found. There were no significant differences in human apoE immunoreactivity among the 3 lines of KI mice in any regions examined. Notably, in each of 2/2-, 3/3-, or 4/4-KI mice subjected to pMCAO, human apoE immunoreactivity in neurons and astrocytes was significantly enhanced in the peri-infarct areas (### p Ͻ 0.001), while it was significantly decreased in the infarct areas (### p Ͻ 0.001) compared with nonischemic areas in both hemispheres.
Concerning alterations in regional CBF, our results showed that there were no significant differences among the 3 lines of KI mice in regional CBF alterations during the 30 min after pMCAO. Nevertheless, evidence for an apoE isoform-specific vascular effect was shown in a report demonstrating that specific human recombinant apoE isoforms at physiologic concentrations (ϳ10 nM) differentially constrict isolated rat aortae (apoE4 Ͼ apoE3, and not apoE2) (34) . In this regard, further studies are needed to clarify the possible implications of vascular factors in apoE isoform-specific neuronal vulnerability.
Quantitation of apoE protein levels in brain homogenates revealed that the abundance of apoE was significantly increased in 2/2 KI mice compared to 3/3 or 4/4 KI mice. As it has been reported that intraventricular infusion of apoE (5 g/ml lipid-conjugated derived from human plasma; 1 l/h, continuous infusion) ameliorates acute neuronal damage (35) , it is likely that the alterations in infarct volumes may reflect variations in the baseline levels of apoE in the different lines of mice. However, our observations about the ischemic damage demonstrated that not only 2/2 but also 3/3 KI mice were significantly less vulnerable than 4/4 KI mice at 24 h after pMCAO. Moreover, immunohistochemical data revealed similarity in the human apoE expression among the 3 lines of KI mice, particularly regarding its intracerebral distribution and intensity, suggesting endogenous regulatory control of the human APOE transgenes. Thus, it seems that the differences in infarct volumes as well as neurologic deficits among the 3 lines of KI mice may have been due to an isoform-specific effect rather than to differences in the levels of apoE expression.
The apoE has been considered to play a pivotal role in membrane remodeling, repair, and regeneration through mobilization and repartitioning of cholesterol and phospholipids (2). Moreover, apoE isoforms have been deemed to play a role in brain damage, as shown by a large body of evidence. For example, the apoE4 isoform has been found to confer neuronal vulnerability (16) (17) (18) 20) , alter neuronal binding to amyloid-␤ peptide (7, 23) , and retard neurotropism (19, 21, 24, 25) . Regarding ischemic cerebrovascular disease, a large meta-analysis of APOE genotypes revealed that the APOE 4 allele was a risk factor for stroke and transient ischemic attacks, whereas the APOE 2 allele did not confer any protection (15) . The results of that study are consistent with the data presented here showing that 4/4 KI mice are more vulnerable to brain damage after pMCAO than 3/3 KI mice, whereas 2/2 KI mice did not show any protection versus 3/3 KI mice. Although the underlying mechanism(s) of this effect are beyond the scope of this study, some pertinent findings were obtained as follows. First, the infarct volume was measured at 24 h after pMCAO in this study. As this time point corresponds to the watershed between the acute and the late infarct expansion in the rat pMCAO model (36) , it may be surmised that either the presence of the APOE 4 allele or the absence of the APOE 2 allele or the APOE 3 allele, or both, acted to aggravate the acute infarct expansion, which has been ascribed to spreading depression-like depolarization (37), microcirculatory derangement (38) , and functional disturbances in mitochondria and/or endoplasmic reticulum, leading to apoptotic or necrotic cell death (39) . On the premise that the apoE4 isoform deranges the metabolism of membrane lipids, it may well be involved in any of the above mechanisms, inducing acute infarct expansion. Furthermore, it has been reported that the synthesis of apoE is upregulated in astrocytes and neurons after transient forebrain ischemia in gerbils (40) , and in transgenic mice expressing the apoE4 isoform (20) . Moreover, in this study, expression of the human apoE was enhanced in neurons and astrocytes located in the peri-infarct areas of the ischemic hemispheres from 2/2, 3/3, or 4/4 KI mice.
Astrocytes are known to be the primary producers of apoE in the brain (4, 5) , generating high-density lipoprotein-like particles with cellular lipids in CSF (41) . These apoE-lipid particles are believed to supply cholesterol to neurons in an apoE-receptor-mediated manner (42) . Recently, using the same lines of KI mice studied here, our group demonstrated that apoE3-expressing astrocytes have a higher ability to generate apoE-lipid particles than apoE4-expressing astrocytes, suggesting that the apoE3 isoform could supply more cholesterol to neurons than the apoE4 isoform, thereby supporting neuronal plasticity and promoting neuronal regeneration (43) . This apoE isoform-specific difference in the production of apoE-lipid particles by astrocytes may contribute to differences in neuronal vulnerability. Importantly, astrocytic activation, of which increased GFAP expression is a hallmark, is evident in the peri-infarct area at 6 h following pMCAO in rats (44) . The fact that human apoE was co-expressed with GFAP in peri-infarct-reactive astrocytes in our study leads us to suspect that the intracellular signaling pathway(s) related to astrocytic activation also participate in upregulation of apoE isoforms. We have recently reported that the infarct volume slowly expands even after 24 h, when peri-infarct reactive astrocytes are prominent (36) . Thus, it seems of importance to clarify whether expression of each apoE isoform in peri-infarct reactive astrocytes is maintained later than 24 h and, in particular, whether the expression of the apoE4 isoform is associated with worsened delayed infarct expansion. As the pathomechanism involved in delayed infarct expansion shares common features with that of neurodegenerative diseases or AIDS dementia (45), the above line of investigation is expected to shed new light on the pathogenic role of the apoE4 isoform in various forms of brain damage.
